Axogen Inc vs Intel Corp — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Intel Corp trades at $110.68 (market cap $541.60B). The key difference: Intel Corp is far larger — about 262.9× Axogen Inc's market cap, and Intel Corp pays a 2.24% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | INTC | |
|---|---|---|
Market Cap | $2.06B | $541.60B |
Sector | Technology | Technology |
52-Week High | $46.19 | $140.94 |
52-Week Low | $11.28 | $19.31 |
Enterprise Value | $1.98B | $553.84B |
Volume | — | 43,552,012 |
Dividend Yield | — | 2.24% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Intel (INTC) trades at $103.12, down 6.12% today, as the stock faces technical bearish signals despite recent earnings beats. The company shows mixed fundamentals with negative net income margins and high valuation ratios, though operating cash flow remains strong at $9.7 billion. Recent news highlights Intel's $5.7 billion AI investment in Ireland while analysts express caution about near-term challenges in the semiconductor sector.
Intel presents a complex investment case with improving operational trends but persistent profitability challenges. The stock offers potential upside to the $105.48 consensus target but faces headwinds from competitive pressures and high capital expenditures. Key catalysts include AI execution and PC market recovery, while risks include margin compression and debt levels.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →